Single Blind Study of AB-729 and VTP-300 in Virologically-Suppressed Chronic Hepatitis B Participant

• Research type

  Research Study

• Full title

  A Phase 2a, Randomized, Blinded, Multicenter Study Investigating a Combination of AB 729 and VTP-300 in Virologically-Suppressed Chronic Hepatitis B Participants

• IRAS ID

  1005946

• Contact name

  Deana Antoniello

• Contact email

  dantoniello@arbutusbio.com

• Sponsor organisation

  Arbutus Biopharma Corporation

• Eudract number

  2022-001946-39

• Research summary

  Single Blind Study of AB-729 and VTP-300 in Virologically-Suppressed Chronic Hepatitis B Participants

• REC name

  London - Dulwich Research Ethics Committee

• REC reference

  22/LO/0618

• Date of REC Opinion

  20 Oct 2022

• REC opinion

  Further Information Favourable Opinion